首页> 外文期刊>The Lancet >Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons.
【24h】

Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons.

机译:由氢氯氟烃用作氯氟烃的节省臭氧的替代物引起的肝病流行。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Hydrochlorofluorocarbons (HCFCs) are used increasingly in industry as substitutes for ozone-depleting chlorofluorocarbons (CFCs). Limited studies in animals indicate potential hepatotoxicity of some of these compounds. We investigated an epidemic of liver disease in nine industrial workers who had had repeated accidental exposure to a mixture of 1,1-dichloro-2,2,2-trifluoroethane (HCFC 123) and 1-chloro-1,2,2,2-tetrafluoroethane (HCFC 124). All nine exposed workers were affected to various degrees. Both compounds are metabolised in the same way as 1-bromo-1-chloro-2,2,2-trifluoroethane (halothane) to form reactive trifluoroacetyl halide intermediates, which have been implicated in the hepatotoxicity of halothane. We aimed to test whether HCFCs 123 and 124 can result in serious liver disease. METHODS: For one severely affected worker liver biopsy and immunohistochemical stainings for the presence of trifluoroacetyl protein adducts were done. The serum of six affected workers and five controls was tested for autoantibodies that react with human liver cytochrome-P450 2E1 (P450 2E1) and P58 protein disulphide isomerase isoform (P58). FINDINGS: The liver biopsy sample showed hepatocellular necrosis which was prominent in perivenular zone three and extended focally from portal tracts to portal tracts and centrilobular areas (bridging necrosis). Trifluoroacetyl-adducted proteins were detected in surviving hepatocytes. Autoantibodies against P450 2E1 or P58, previously associated with halothane hepatitis, were detected in the serum of five affected workers. INTERPRETATION: Repeated exposure of human beings to HCFCs 123 and 124 can result in serious liver injury in a large proportion of the exposed population. Although the exact mechanism of hepatotoxicity of these agents is not known, the results suggest that trifluoroacetyl-altered liver proteins are involved. In view of the potentially widespread use of these compounds, there is an urgent need to develop safer alternatives.
机译:背景技术:氢氯氟烃(HCFC)在工业中越来越多地用作消耗臭氧的氯氟烃(CFC)的替代品。对动物的有限研究表明,其中某些化合物具有潜在的肝毒性。我们调查了9名工业工人的肝病流行病,这些工人反复意外接触1,1-二氯-2,2,2-三氟乙烷(HCFC 123)和1-氯-1,2,2,2 -四氟乙烷(HCFC 124)。所有九名裸露的工人都受到不同程度的影响。两种化合物都以与1-溴-1-氯-2,2,2-三氟乙烷(氟烷)相同的方式代谢,形成反应性三氟乙酰卤化物中间体,这与氟烷的肝毒性有关。我们旨在测试HCFCs 123和124是否会导致严重的肝脏疾病。方法:对一名严重受影响的工人进行肝活检,并进行免疫组织化学染色以检测是否存在三氟乙酰基蛋白加合物。测试了六名受影响工人和五个对照的血清中与人肝细胞色素P450 2E1(P450 2E1)和P58蛋白二硫键异构酶同工型(P58)反应的自身抗体。结果:肝活检标本显示肝细胞坏死在三周围区突出,并从门道一直延伸到门道和小叶区(桥状坏死)。在存活的肝细胞中检测到三氟乙酰基加成的蛋白质。在五名受影响工人的血清中检测到了先前与氟烷肝炎相关的针对P450 2E1或P58的自身抗体。解释:人类反复暴露于HCFCs 123和124会在大部分暴露人群中导致严重的肝损伤。尽管这些药物的肝毒性确切机制尚不清楚,但结果表明涉及三氟乙酰基改变的肝蛋白。鉴于这些化合物的潜在广泛使用,迫切需要开发更安全的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号